JUNE 17-19, 2024    
WASHINGTON, DC   

 

Tissue Engineering and Disease Modeling


Symposium Chair

Thomas J. WebsterThomas J. Webster
Chief Scientific Advisor
Interstellar Therapeutics

 

Key Speakers

Sougata GhoshFabrication of phytogenic nanocomposites as novel anticancer nanomedicine
Sougata Ghosh
Visiting Professor, RK University

Houssam Bouloussa4D Printing Technology Confers Remote Control Shape Change Properties to Biomaterials
Houssam Bouloussa
Assistant Professor, University of Missouri - Kansas City

Steven ZanganehAdvancing Chronic Wound Healing through Immune System Modulation Strategies
Steven Zanganeh
Assistant Professor, New York Institute of Technology

Stefan LohfeldOpportunities and challenges with 4D smart materials for tissue engineering
Stefan Lohfeld
Assistant Professor, University of Missouri-Kansas City

Tissue engineering encompasses aspects of cells, materials, and biochemical, and physiochemical cues to restore, maintain, or replace tissue function. Disease modeling, whether it be in vitro or in vivo, aims to establish systems that resemble human diseases to improve our understanding of the mechanism of diseases or develop new therapies and diagnostic tools. Though these two areas are distinctly different in their end goals, there is significant conceptual and design overlap. Presentations in this session focus all aspects of tissue engineering or disease modeling including biomaterials, cells, growth factors, mechanical stimuli, and in vivo models and testing.

 
Back to Top ↑

2024 Symposium Sessions

Tuesday June 18

1:30Medical Devices & Tissue Engineering
4:00Tissue Engineering - Posters

Wednesday June 19

9:00Tissue Engineering & Infection Control

2024 Symposium Program

Tuesday June 18

1:30Medical Devices & Tissue EngineeringChesapeake B
Session chair: Jeannine M. Coburn, Worcester Polytechnic Institute & Thomas Webster, Interstellar Therapeutics, US
Engineering a temporary replacement biomimetic retinal tamponade hydrogel
G.J.C. Braithwaite, M. Xheka, Cambridge Polymer Group, Inc., US
Transforming Battlefield Trauma Care: Assessing the Universal Combat Matrix in Preclinical Models of Burns, Junctional Hemorrhage, and Non-Compressible Torso Hemorrhage
A.M. Jorgensen, F. Marini, T. Shupe, J. Rall., J. Radowsky, L. Paladino, W.L. Hickerson, SiOxMed, LLC, US
Antimicrobial Peptide Functionalized Bacterial Cellulose for Wound Dressing Applications
E.M. van Zyl, J.M. Coburn, Worcester Polytechnic Institute, US
WoundSentry: A Revolutionary AI-Driven Wearable for Enhanced Infection Detection
T.J. Ko, L. Yeh, P. Lubet, J. Wang, A. Gnatt, X.L. Liu, Nanobiofab, US
The Combined Effect of Photobiomodulation and Nanoparticle-based Biomaterials for the Treatment of Pathogen-Infected Wounds
S.S. Dhilip Kumar, H. Abrahamse, University of Johannesburg, ZA
AFM Probe Manufacturing: Challenges and Limitations from the Industry's Perspective
O. Krause, NanoWorld AG, DE
4:00Tissue Engineering - PostersExpo Hall BC
Using Low Temperature Plasma (LTP) to Develop Scaffolds with Antimicrobial Properties for Tissue Regeneration
K. Vig, A. Azzouz, M. Zafaryab, Alabama State University, US
Advancing Antimicrobial Scaffolds for Tissue Regeneration Using Low Temperature Plasma (LTP)
K. Vig, A. Azzouz, M. Zafaryab, Alabama State University, US
Advancements in 3D-Printed Bone Scaffolds and Intramedullary Nail Systems: In Vitro Evaluation and Rabbit Tibia Model Assessment
S. Saleemi, O. Oti, A. Haleem, A.A. Moussa, M. Khandaker, University of Central Oklahoma, US

Wednesday June 19

9:00Tissue Engineering & Infection ControlNational Harbor 4
Session chair: Thomas Webster, Interstellar Therapeutics, US
Fabrication of phytogenic nanocomposites as novel anticancer nanomedicine
S. Ghosh, T.J. Webster, Kasetsart University, TH
Advancing Chronic Wound Healing through Immune System Modulation Strategies
S. Zanganeh, New York Institute of Technology (NYIT), US
Opportunities and challenges with 4D smart materials for tissue engineering
S. Lohfeld, University of Missouri-Kansas City, US
A Real BandAId: A Review of Incorporating Artificial Intelligence (AI) into Tissue Engineering
T.J. Webster, Hebei University of Technology and Interstellar Therapeutics, US
4D Printing Technology Confers Remote Control Shape Change Properties to Biomaterials
H. Bouloussa, University of Missouri-Kansas City,, US
Topics & Application Areas
  • Cell sourcing
  • Genetic and metabolic engineering
  • Growth factor and cytokines
  • Tissue stimulation devices
  • Biomaterials for tissue engineering or disease modeling
  • Three-dimensional cell culture models
  • Organ-on-a-chip
  • Microphysiological systems
  • Drug screening platforms
  • Engineered models of diseases
  • Animal models
  • Models to study host-microorganism interactions and infections
  • Other
 

Sponsor & Exhibitor Opportunities
 

To receive announcements and news, please join our mailing list.

Click here to add this event to your calendar.
..  
 
2024 SPONSORS & PARTNERS
Sponsors & Partners
 
2024 SBIR/STTR AGENCY PARTNERS
SBIR/STTR Agency Partners